A Sequential Two-Stage Dose Escalation Study to Evaluate the Safety and Efficacy of Ruxolitinib
Clinical trial NCT01776723 · COMPLETED
Trial details
- NCT number
- NCT01776723
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-20
- Primary completion
- 2018-11-28
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.